Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

NCT05690204 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: SAP-001

Sponsor

Shanton Pharma Pte. Ltd.